NETZSCH Group
Thermal Analysis Techniques and Rheometers for the Pharmaceutical Industry
Ovarian cancer is the most lethal gynaecologic cancer and is currently a leading cause of mortality across the world. The disease is characterised by excessive cell growth in the ovaries, although research postulates that the disease could originate in the fallopian tubes.
GlobalData’s report outlines the epidemiology of ovarian cancer, creating a forecast for incidents and cases over the next 5 years. Data such as age and sex-specific diagnosed incidents are used to forecast the future prevalence of the disease. Throughout the research, the relationship between age and survival rates is explored in order to estimate cases in different areas of the world.
Ovarian cancer incident rates are set to increase from 63,331 in 2018 to 66,000 in 2028, showing an annual growth rate of 0.42% The US currently has the highest number of diagnosed incidents and 5-year prevalent cases of ovarian cancer, and this is set to continue.
Key highlights of this report are:
The report ‘Ovarian Cancer: Epidemiology Forecast to 2028’ offers a chance for you to quantify populations in the global market and use this information to develop business strategies. You will be able to use data to understand the ovarian cancer market and identify key opportunities to drive sales efforts.
Latest report from
Browse over 50,000 other reports on our store.
Visit GlobalData Store
Thermal Analysis Techniques and Rheometers for the Pharmaceutical Industry
Inhalation Product Development for the Pharmaceutical Industry
Pharmaceutical Water, Pure Water, Water for Injection and Pure Steam Equipment